CDMOs

R&D

Seamless scale-up: Integrated manufacturing becomes the biop...

Today, the demand for speed, quality, and scalability is pushing the industry towards a different model: integrated manufacturing.

News

J&J earmarks $2bn for facility in North Carolina

Johnson & Johnson has filled in some of the detail in its $55 billion investment in US facilities announced earlier this year.

R&D

The sparkling opportunity of precision medicine represented by glittering DNA strand

Built for one: The case for custom formulation in the era of...

The precision medicine market is projected to exceed $175 billion by 2030, reflecting continued growth and interest in innovative approaches that tailor therapeutics that accounts for diffe

R&D

How small molecule-focused CDMOs can navigate the impact of ...

As large-molecule drugs and weight-loss therapeutics dominate headlines, the pharmaceutical industry faces legislative pressures, funding cuts, and cascading supply chain disruptions.

News

Tobacco firm PMI divests Vectura at a loss after backlash

Philip Morris International (PMI) is selling inhaled drug specialist Vectura to Molex Asia Holdings for a fraction of the £1.1 billion ($1.45 billion) it paid for the business three years a

Digital

Changing Faces – Digital and supplier hires from July 2024

Welcome back to Changing Faces for the month of July. Today we’re looking at CROs, CDMOs, suppliers, and tech vendors – the industry around pharma that keeps pharma ticking.